Early Treatment for Acute ACL Tear

Completed · Phase 2 · Has a placebo group

Conditions studied: Anterior Cruciate Ligament (ACL) Tears

In brief

This research study is the first of its kind and will allow health care professionals and researchers to answer many questions about the reasons why anterior cruciate ligament (ACL) injury leads to knee pain and disability and osteoarthritis. We also hope that this study will be the beginning of new, more powerful and safer drugs to help patients with ACL injuries heal sooner and return to sports or daily activities pain free. Study participants will be recruited from the University of Kentucky and Vanderbilt University. The purpose of this research is to gather information on how safe and effective Kenalog® is in alleviating knee pain following ACL rupture.

Key facts

Study ID
NCT01692756
Run by
Cale Jacobs
People needed
49
Starts
2013-03-01
Expected to finish
2017-02-05
Last updated by the study team
2018-12-05

Who can join

Age: 14 and older, up to 33. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.